Adults who have a diagnosis of moderate to severe plaque psoriasis (plaque PsO) may qualify for this clinical research trial and receive investigational oral medication (JNJ-77242113) or placebo.

  • Age: ≥ 12 years and ≤ 70 years old
  • BSA ≥ 10, PASI ≥ 12, IGA ≥ 3
  • Diagnosis of Plaque PsO within the past 6 months

Patients will be asked to visit the clinic about 24 times over approximately 165 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel.

For further information on the study, please follow the link:

Study Details | A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis | ClinicalTrials.gov

Trial ID: NCT06095115


If you are interested and would like to participate in this trial, please register your details and answer a few short questions for our recruitment team to back to you: eligibility questionnaire

I’m interested & would like to participate in this trial

Book Appointment